Inhibrx Biosciences, Inc.
Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

Abstract:

The disclosure relates generally to molecules that specifically engage death receptor 5 (DR5), a member of the TNF receptor superfamily (TNFRSF) and methods of treatment. More specifically the disclosure relates to multivalent and multispecific molecules that bind at least DR5.